Beam And Verve Benefit From Buzz Around Base-Editing Therapies
Excitement Around Next-Gen Gene-Editing
Verve's CEO Sekar Kathiresan. The company is working in partnership with Beam Therapeutics on bringing base edited gene therapies to market. • Source: Verve Therapeutics
